About PERSISTA BIO INC
Persista Bio is a seed-stage company developing biotherapeutic implants for the treatment of Type 1 diabetes, with a focus on long-term cell therapy solutions that mimic natural body processes. Their O2Line™ system has shown success in preclinical trials with diabetic rats.
Development of long-term cell implants for disease treatmentCell encapsulation and electrochemical technology expertiseLicensing of technology from Cornell University and Giner, Inc.Preclinical testing and prototype development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PERSISTA BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.